Clinical Trial Update: ExAblate Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's Disease [NA]

View source ↗

Summary

A completed clinical trial investigating ExAblate transcranial MR-guided focused ultrasound for Parkinson's disease, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Exablate

Snippet

Sponsor: InSightec | Conditions: Parkinson's Disease | NA | Status: COMPLETED | Results posted: 2020-10-09